Astellas serves up dose of "reality" in DTC effort

Share this article:
Astellas serves up dose of "reality" in DTC effort
Astellas serves up dose of "reality" in DTC effort

"Slice of life" is a common trope in pharmaceutical advertising. Commercials with people in sandals walking down a beach, as a voiceover intones benefits and risks, connote one form. "Slice of life" can also be about acknowledging that a problem exists in the first place.

Overactive bladder (OAB) lends itself to the latter. Although 46 million Americans suffer from OAB, only 10-20% of them are seeking treatment options.

"This condition is very prevalent,” said Pamela Buford, director of consumer marketing, urology, for Astellas Pharma US, maker of OAB treatments Myrbetriq and VESIcare. She told MM&M, “People don't know that the things they're experiencing are very common, and that they do display specific symptoms. We want to highlight that this is [their] reality.”

With that goal as a centerpiece, Astellas rolled out “OAB Reality,” an unbranded campaign aimed at addressing some misconceptions: “Is [OAB] really a medical condition? Is this something you can do something about? Is it just a product of getting older?” Buford explained.

The campaign keys in specifically on common experiences for female sufferers. Astellas chose to focus on the women's side of OAB instead of a unisex campaign. OAB symptoms in men can often mimic those of benign prostatic hyperplasia (BPH) and prostate cancer—which makes communications that much more difficult.

One of the “common experiences” with OAB, said Buford, is that sufferers need to “map out their bathrooms for everything they need to do.” Another oft-overlooked aspect of the disorder is the “amount of quality interruptions in your life that result from this disorder and that you carry around with you all the time. They significantly impact your life,” she said.

The campaign depicts women carrying around large numbers in such settings as the movies, golf course and office to symbolize the weight of those "quality interruptions" on sufferers' day-to-day lives. The 30-second spots are currently running on Lifetime, NBC and CBS.

Astellas also offers information online at OABreality.com, through a partnership with Healthywomen.org. OAB Reality will additionally surface in radio spots on NBC and CNN networks and will find its way to the doctor's office in the form of brochures and other in-office communications.

Buford says that initial results from the multi-channel campaign are “very encouraging; we've received a lot of positive activity on the properties and a lot of great feedback.”

Roska Healthcare Advertising, which won the account a year ago, is Astellas's creative agency of record. Edelman handles PR.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...